BioMarin
Financial
Business Segments
| Segments | 2024 ($ Millions) |
|---|---|
| VIMIZIM | *** |
| NAGLAZYME | *** |
| PALYNZIQ | *** |
| BRINEURA | *** |
| ALDURAZYME | *** |
| VOXZOGO | *** |
| KUVAN | *** |
| ROCTAVIAN | *** |
Business Segments Chart
Business Regions
| Regions | 2024 ($ Millions) |
|---|---|
| U.S. | *** |
| Europe | *** |
| Latin America | *** |
| Rest of World | *** |
| ALDURAZYME product revenues marketed by Sanofi | *** |
Business Regions Chart
This information is available for BCC Research members only.
BCC Research Beacon 